atomoxetine stada 80 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 80 mg - atomoxetinhydroklorid 91,44 mg aktiv substans
atomoxetine stada 18 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 18 mg - atomoxetinhydroklorid 20,574 mg aktiv substans
atomoxetine stada 25 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 25 mg - atomoxetinhydroklorid 28,575 mg aktiv substans
atomoxetine stada 60 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 60 mg - atomoxetinhydroklorid 68,58 mg aktiv substans
atomoxetine stada 40 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 40 mg - atomoxetinhydroklorid 45,72 mg aktiv substans
atomoxetine stada 100 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 100 mg - atomoxetinhydroklorid 114,3 mg aktiv substans
atomoxetine stada 10 mg kapsel, hård
stada arzneimittel ag - atomoxetinhydroklorid - kapsel, hård - 10 mg - atomoxetinhydroklorid 11,43 mg aktiv substans
adempas
bayer ag - riociguat - hypertoni, lungformig - antihypertensiva medel mot pulmonell arteriell hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekt har visats i ett pah befolkning, inklusive aetiologies av idiopatisk eller ärftlig polycykliska aromatiska kolväten eller pah som associeras med bindvävssjukdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
sumatriptan stada 100 mg tablett
stada arzneimittel ag - sumatriptansuccinat - tablett - 100 mg - laktosmonohydrat hjälpämne; sumatriptansuccinat 140 mg aktiv substans - sumatriptan